Les données financières de cette entreprise sont partiellement disponibles (liasse simplifiée ou données confidentielles). Certaines sections ne sont pas affichées.

PHARMACIE MORER COTTALORDA : revenue, balance sheet and financial ratios

PHARMACIE MORER COTTALORDA is a French company founded 8 years ago, specialized in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé. Based in FRONTIGNAN (34110), this company of category PME shows in 2025 a net income positive of 82 k€. Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.

Data updated on 2026-05-09

Sources : INPI & INSEE SIRENE - Processing : Ministry of Economy

Financial history - PHARMACIE MORER COTTALORDA (SIREN 835230087)
Indicator 2025 2024 2023 2022 2021 2020 2019
Revenue N/C N/C N/C N/C N/C N/C N/C
Net income 81 629 € 72 126 € 123 114 € 180 569 € 119 534 € 66 460 € 116 051 €
EBITDA N/C N/C N/C N/C N/C N/C N/C
Net margin N/C N/C N/C N/C N/C N/C N/C

Revenue and income statement

In 2025, PHARMACIE MORER COTTALORDA generates positive net income of 82 k€. Net income represents the final profit after all expenses (operating, financial, exceptional) and corporate tax. Change over 2019-2025: 116 k€ -> 82 k€.

Net income (2025) ?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax

81 629 €

Loading income statement...

Chart evolution

Show :

Assets

Loading data...

Liabilities

Loading data...

Solvency and debt ratios

The debt ratio (= Financial debt / Equity x 100) stands at 43%. Debt remains under control: the company retains capacity to raise new debt if needed. Financial autonomy (= Equity / Total assets x 100) reaches 57%. This high autonomy means the company finances most of its assets through equity, a sign of strength.

Debt ratio (2025) ?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low
50-100% : Moderate
> 100% : High

43.26%

Financial autonomy (2025) ?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy
20-30% : Average
< 20% : Low

57.156%

Asset age ratio (2025) ?
Asset age ratio
Definition
Measures the degree of wear of tangible assets.
Formula
Accumulated depreciation / Gross fixed assets x 100
Interpretation
< 50% : Recent assets
50-70% : Normal wear
> 70% : Aging assets

21.8%

Solvency indicators evolution
PHARMACIE MORER COTTALORDA

Sector positioning

Debt ratio
43.26 2025
2023
2024
2025
Q1: 13.7
Med: 49.79
Q3: 129.09
Good -7 pts over 3 years

In 2025, the debt ratio of PHARMACIE MORER COTTALORDA (43.26) ranks below the median of the sector. This ratio measures the weight of debt relative to equity. This controlled position reflects prudent management.

Financial autonomy
57.16% 2025
2023
2024
2025
Q1: 33.42%
Med: 53.72%
Q3: 72.08%
Good +7 pts over 3 years

In 2025, the financial autonomy of PHARMACIE MORER COTTALORDA (57.2%) ranks above the median of the sector. This ratio represents the share of equity in total financing. This comfortable position offers an appreciable safety margin.

Liquidity ratios

The liquidity ratio (= Current assets / Current liabilities) stands at 143.16. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.

Liquidity ratio (2025) ?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good
1-1.5 : Fair
< 1 : Liquidity risk

143.155

Liquidity indicators evolution
PHARMACIE MORER COTTALORDA

Sector positioning

Liquidity ratio
143.16 2025
2023
2024
2025
Q1: 131.03
Med: 182.25
Q3: 258.64
Average -8 pts over 3 years

In 2025, the liquidity ratio of PHARMACIE MORER COTTALORDA (143.16) ranks below the median of the sector. This ratio measures the ability to cover short-term debt with current assets. An improvement would strengthen the competitive position.

Positioning of PHARMACIE MORER COTTALORDA in its sector

Comparison with sector Commerce de détail de produits pharmaceutiques en magasin spécialisé

Valuation estimate

Based on 277 transactions of similar company sales in 2025, the value of PHARMACIE MORER COTTALORDA is estimated at 1 296 686 € (range 879 937€ - 2 034 679€). This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.

Estimated enterprise value 2025
277 transactions
879k€ 1296k€ 2034k€
1 296 686 € Range: 879 937€ - 2 034 679€
NAF 5 année 2025

Valuation method used

Net Income Multiple
81 629 € × 15.9x = 1 296 686 €
Range: 879 937€ - 2 034 679€

Only this financial indicator is available for this company.

Valuation evolution

How is this estimate calculated?

This estimate is based on the analysis of 277 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.

  • EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
  • Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
  • Net Income Multiple: Relevant for mature companies with stable results.

This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).

Similar companies (Commerce de détail de produits pharmaceutiques en magasin spécialisé)

Compare PHARMACIE MORER COTTALORDA with other companies in the same sector:

Voir toutes les statistiques du secteur Commerce de détail de produits pharmaceutiques en magasin spécialisé

Frequently asked questions about PHARMACIE MORER COTTALORDA

What is the revenue of PHARMACIE MORER COTTALORDA ?

The revenue of PHARMACIE MORER COTTALORDA is not publicly disclosed (confidential accounts filed with INPI).

Is PHARMACIE MORER COTTALORDA profitable?

Yes, PHARMACIE MORER COTTALORDA generated a net profit of 82 k€ in 2025.

Where is the headquarters of PHARMACIE MORER COTTALORDA ?

The headquarters of PHARMACIE MORER COTTALORDA is located in FRONTIGNAN (34110), in the department Herault.

Where to find the tax return of PHARMACIE MORER COTTALORDA ?

The tax return of PHARMACIE MORER COTTALORDA is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).

In which sector does PHARMACIE MORER COTTALORDA operate?

PHARMACIE MORER COTTALORDA operates in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé (NAF code 47.73Z). See the 'Sector positioning' section above to compare the company with its competitors.